ProfileGDS4718 / 227727_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 60% 63% 99% 56% 64% 47% 50% 56% 72% 66% 65% 53% 53% 57% 54% 82% 62% 61% 52% 60% 68% 72% 66% 66% 64% 55% 65% 50% 57% 52% 44% 90% 60% 58% 77% 62% 50% 63% 51% 99% 59% 46% 89% 56% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.1081660
GSM549102patient 115, normal, homogenized [OPG study]6.3540963
GSM549104patient 119, normal, homogenized [OPG study]12.585799
GSM549108patient 138, normal, homogenized [OPG study]5.926256
GSM549119patient 077, normal, homogenized [OPG study]6.4158664
GSM549133patient 032, cancer, homogenized [OPG study]5.2976847
GSM549139patient 042, cancer, homogenized [OPG study]5.4860150
GSM549099patient 107, normal, homogenized [OPG study]5.843856
GSM549109patient 139, normal, homogenized [OPG study]7.0447872
GSM549110patient 046, normal, homogenized [OPG study]6.5400366
GSM549114patient 063, normal, homogenized [OPG study]6.4482365
GSM549122patient 082, normal, homogenized [OPG study]5.7186453
GSM549134patient 033, cancer, homogenized [OPG study]5.665453
GSM549136patient 036, cancer, homogenized [OPG study]5.8920657
GSM549140patient 044, cancer, homogenized [OPG study]5.7237454
GSM549111patient 047, normal, homogenized [OPG study]8.1429982
GSM549113patient 057, normal, homogenized [OPG study]6.2579262
GSM549132patient 031, cancer, homogenized [OPG study]6.2251261
GSM549137patient 038, cancer, homogenized [OPG study]5.6026952
GSM549142patient 047, cancer, homogenized [OPG study]6.2333460
GSM549100patient 110, normal, homogenized [OPG study]6.6756368
GSM549107patient 135, normal, homogenized [OPG study]7.0409172
GSM549115patient 068, normal, homogenized [OPG study]6.5853166
GSM549116patient 072, normal, homogenized [OPG study]6.5966366
GSM549120patient 078, normal, homogenized [OPG study]6.3868464
GSM549131patient 030, cancer, homogenized [OPG study]5.7544755
GSM549118patient 074, normal, homogenized [OPG study]6.4923165
GSM549129patient 027, cancer, homogenized [OPG study]5.5219350
GSM549123patient 088, normal, homogenized [OPG study]5.9498657
GSM549124patient 006, cancer, homogenized [OPG study]5.6765752
GSM549126patient 015, cancer, homogenized [OPG study]5.1710444
GSM549128patient 025, cancer, homogenized [OPG study]9.1330590
GSM549103patient 117, normal, homogenized [OPG study]6.1304460
GSM549117patient 073, normal, homogenized [OPG study]5.9365358
GSM549138patient 041, cancer, homogenized [OPG study]7.5734677
GSM549141patient 045, cancer, homogenized [OPG study]6.2962762
GSM549130patient 028, cancer, homogenized [OPG study]5.5380750
GSM549101patient 111, normal, homogenized [OPG study]6.3359463
GSM549105patient 128, normal, homogenized [OPG study]5.6090251
GSM549106patient 134, normal, homogenized [OPG study]12.272199
GSM549112patient 048, normal, homogenized [OPG study]6.0563159
GSM549125patient 011, cancer, homogenized [OPG study]5.308946
GSM549127patient 024, cancer, homogenized [OPG study]8.9093589
GSM549135patient 035, cancer, homogenized [OPG study]5.8640156